<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>110</id><JournalTitle>REVIEW ON DEVELOPMENT OF ORPHAN DRUG</JournalTitle><Abstract>A rare disease, also referred to as an "orphan disease", is any disease that affects a small percentage of the population.
Most rare diseases are genetic, and thus are present throughout the person's entire life, even if symptoms do not immediately
appear. Many rare diseases appear early in life, and about 30 percent of children with rare diseases will die before reaching
their fifth birthday. With a single diagnosed patient only, ribose-5-phosphate isomerase deficiency is presently considered the
rarest genetic disease. No single cutoff number has been agreed upon for which a disease is considered rare. A disease may be
considered rare in one part of the world, or in a particular group of people, but still be common in another.</Abstract><Email>saisujji16@gmail.com</Email><articletype>Review</articletype><volume>8</volume><issue>2</issue><year>2018</year><keyword>Orphan disease, Regulatory harmonization, Orphan drug.</keyword><AUTHORS>Sai Sujitha G,Sreekanth Reddy CP,Jyoshtna Devi K,Jayachandra Reddy P</AUTHORS><afflication>Sai Sujitha G,Sreekanth Reddy CP,Jyoshtna Devi K,Jayachandra Reddy P</afflication></Article></Articles>